Dr. Jesse Keller is an Oncologist at the St. Louis VA and works on several secondary research projects.
Dr. Keller serves as Co-Investigator on several Clinical Trials such as CANOPY and Talapro-2 Dr. Keller holds a DOD Prime award for his project 'A Novel Risk Prediction Model for Checkpoint Inhibitor–Related Autoimmune Toxicities' which is in the data analysis stages. |